Khayelitsha 2001 - 2011: 10 Years of primary care HIV and TB programmes

Southern African Journal of HIV Medicine

Volumn , Issue 42, 2011, Pages 33-38

  Garone, Daniela Belen ^a,b   Hilderbrand, Katherine ^a,b   Boulle, Andrew M ^b   Coetzee, David ^b   Goemaere, Eric ^a,b   Van Cutsem, Gilles ^a,b   Besada, Donela ^a,b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DARUNAVIR; STAVUDINE; TENOFOVIR; TUBERCULOSTATIC AGENT;

BACTERIUM DETECTION; CD4 LYMPHOCYTE COUNT; CHEMOPROPHYLAXIS; COMMUNITY CARE; CONDOM; DECENTRALIZATION; DRUG COST; DRUG FORMULATION; DRUG RESISTANT TUBERCULOSIS; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOXICITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SERVICE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; PAPANICOLAOU TEST; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT REFERRAL; POINT OF CARE TESTING; PREGNANCY TERMINATION; PRIMARY MEDICAL CARE; REVIEW; SCREENING TEST; SEXUAL BEHAVIOR; SEXUAL HEALTH; SEXUALLY TRANSMITTED DISEASE; TUBERCULOSIS; VERTICAL TRANSMISSION; VIRUS LOAD;

EID: 84856201539     PISSN: 16089693     EISSN: None     Source Type: Journal    
DOI: 10.4102/sajhivmed.v12i4.170     Document Type: Review

References (12)

1. Médecins Sans Frontières. Khayelitsha 2001-2011 activity report: 10 years of HIV/TB care at primary health care level. June 2011. HYPERLINK "http://wwwmsf.org.za/publication/khayelitsha-activity-report- 2001-2011-10-years-hivtb-care-primary-health-care-level" http://wwwmsforgza/publication/khayelitsha-activity-report-2001-2011-10-years- hivtb-care-primary-health-care-level (accessed 11 August 2011).
2. Boulle A, Hilderbrand K, Menten J, et al. Exploring HIV risk perception and behaviour in the context of antiretroviral treatment: results from a township household survey. AIDS Care 2008;20(7):771-781.
3. South African Department of Health. A million condoms a month. 2010. HYPERLINK "http://www.doh.govza/docs/hiv/million-condomspdf" http://www doh.govza/docs/hiv/million-condomspdf (accessed 11 August 2011).
4. Boulle A, Van Cutsem G, Hildebrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS 2010;24(4):563-572.
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365(6):493-505.
6. Boulle A, Orrel C, Kaplan R, et al. Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort. Antivir Ther 2007;12(5):753-760. (Pubitemid 47235489)
7. Brown C, Kerschberger B, Boulle A, et al. TB and HIV service integration within a South African primary health care setting reduces the time to ART initiation without negatively impacting TB outcomes. Presented at the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011), 27 February - 2 March 2011, Boston, USA. Abstract 890. HYPERLINK "http:// wwwretroconference.org/2011/Abstracts/41110.htm"http.//www. retroconferenceorg/2011/Abstracts/41110.htm (accessed 11 August 2011).
8. Médecins Sans Frontières, Partners in Health, Treatment Action Group. An evaluation of drug-resistant TB treatment scale-up. Switzerland, July 2011. HYPERLINK "http://www.ghdonline.org/uploads/DRTB- Report-A4-Final.pdf"http://www.ghdonlineorg/uploads/DRTB-Report-A4-Final. pdf (accessed 11 August 2011).
9. Van Cutsem G, Ford N, Hildebrand K, et al. Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis. PLoS One 2011;6(2):e14684.
10. Kerschberger B, Boulle A, Hilderbrand K, Coetzee D, Goemaere E, Van Cutsem G. Viral load at 3 months associated with better virologic outcomes than at 6 months. Presented at the 6th IAS Conference, 17-20 July 2011, Rome. MOPE144. http://pag.ias2011.org/Abstracts.aspx?AID=3320 (accessed 11 August 2011).
11. Cox HS, McDermid C, Azevedo V, et al. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One 2010;5(11).e13901.
12. Médecins Sans Frontières. Scaling up diagnosis and treatment of drug-resistant tuberculosis in Khayelitsha, South Africa. An integrated, community-based approach. March 2011. HYPERLINK "http://www. msf.org.za/system/files/publication/documents/DR-TB-in-Khayelitsha-Mar2011.pdf? download=1"http://www.msf.orgza/system/files/publication/documents/ DR-TB-in-Khayelitsha-Mar2011.pdf?download=1 (accessed 11 August 2011).